Amphetamine is the most common synthetic stimulant available in Europe, constituting a large and stable market worth a minimum of EUR 1.1 billion annually. In a new analysis released today — EU Drug Market: Amphetamine — two EU agencies highlight sophisticated EU-based amphetamine production, as well as the impact of production on the environment (1).
The analysis, from the EMCDDA and the European Union Agency for Law Enforcement Cooperation (Europol), covers the supply chain from production and trafficking to distribution and use. It also details the processes, materials and criminal actors…